Acute graft-versus-host disease (GVHD) is a common immune complication that can occur
after allogeneic haematopoietic cell transplantation (alloHCT). Acute GVHD is a major …

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the expansion
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …

Posttransplantation cyclophosphamide (PTCy), given on days+ 3 and+ 4, reduces graft-
versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT), but …

The immunosuppressive tumor microenvironment (TME) supports the development of
tumors and limits tumor immunotherapy, including hematological malignancies …

Allogeneic cell therapies, defined by genetically mismatched transplantation, have the
potential to become a cost-effective solution for cell-based cancer immunotherapy. However …

Myeloid-derived suppressor cells (MDSCs) are immature cells of myeloid origin that have
gained researchers' attention, as they constitute promising biomarkers and targets for novel …

Background Pathological cardiac hypertrophy is linked to immune-inflammatory injury, and
regulatory T cells (Tregs) play a crucial role in suppressing immune-inflammatory …

The development of graft versus host disease (GVHD) represents a long-standing
complication of allogeneic hematopoietic cell transplantation (allo-HCT). Different …

Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of
myeloid cells that suppress immune responses in cancer, infection, and trauma. They mainly …

Recent studies demonstrated that myeloid-derived suppressor cells (MDSCs) are involved
in the pathogenesis and progression of multiple myeloma (MM). Nevertheless, data on the …